LXEO
USDLexeo Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$8.300
Kõrge
$8.355
Madal
$7.660
Maht
2.85M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
597.8M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.04M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Equity InsiderNews Commentary – Conventional small molecule approaches have struggled to address genetic defects and complex disease mechanisms,...
HC Wainwright & Co. Maintains Buy on Lexeo Therapeutics, Lowers Price Target to $13
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Lexeo Therapeutics with a Buy and lowers the price target from $15 to $13.
Chardan Capital Maintains Buy on Lexeo Therapeutics, Raises Price Target to $17
Chardan Capital analyst Geulah Livshits maintains Lexeo Therapeutics with a Buy and raises the price target from $15 to $17.
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
U.S. Food and Drug Administration (FDA) open to pooling data from ongoing Phase I/II studies of LX2006 with pivotal data to support a Biologics License Application (BLA) for Accelerated Approval Interim clinical data
Seotud aktsiad
FIZZ
National Beverage Corp.
NYMTZ
New York Mortgage Trust Inc. 7.000% Series G Cumulative Redeemable Preferred Stock $0.01 par value per share
CCM
Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) ordinary shares)
EE
Excelerate Energy Inc.
PLL
Piedmont Lithium Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.